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Aberrant activation of inflammation and excess accumulation of lipids play crucial
role in the occurrence and progression of atherosclerosis (AS). Quercetin (QCT) has
been tested effectively to cure AS. It is widely distributed in plant foods and has
been proved to have potential antioxidative and anticancer activities. However, the
underlying molecular mechanisms of OCT in AS are not completely understood. In
the present study, we stimulated murine RAW264.7 cells with lipopolysaccharide
(LPS) or oxidized low-density lipoproteins (ox-LDL) to mimic the development of
AS. The data show that QCT treatment leads to an obvious decrease of multiple
inflammatory cytokines in transcript level, including interleukin (IL)-1α, IL-1β, IL-2,
IL-10, macrophage chemoattractant protein-1 (MCP-1), and cyclooxygenase-2 (COX-2)
induced by LPS. Moreover, expressions of other factors that contribute to the AS
development, such as matrix metalloproteinase-1 (MMP-1) and suppressor of cytokine
signaling 3 (SOCS3) induced by LPS are also downregulated by QCT. Furthermore, we
found that QCT suppressed LPS-induced the phosphorylation of STAT3. Meanwhile,
QCT could ameliorate lipid deposition and overproduction of reactive oxygen species
induced by ox-LDL, and block the expression of lectin-like oxidized LDL receptor-1
(LOX-1) in cultured macrophages. Taken together, our data reveal that QCT has obvious
anti-inflammatory and antioxidant virtues and could be a therapeutic agent for the
prevention and treatment of AS.
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INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide (Jiang
et al., 2013), with more than 16 million death annually due to its complications. Atherosclerosis
(AS) is responsible for a large proportion of cardiovascular related mortality (Liu et al., 2016).
As a complex and chronic progressive inflammatory disease, AS is characterized by the abnormal
accumulation of fibrous elements and lipids in large and medium-sized arteries. AS is frequently
asymptomatic for several decades until the occurrence of severe cardiovascular disorders such as
stroke or heart attack (Bale et al., 2016).
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Inflammation is involved in every stage of AS, ranging from
injury in vessel endothelial cells to the rupture of plaque in
the end. In series of cellular events for the progression of
AS, formation of lipid-laden macrophages (foam cells) plays
a vital role in response to the inflammation-associated stimuli
(Angelovich et al., 2015). Typically, its formation is associated
with a state of hyperlipidaemia and abnormal accumulation
of ox-LDL. A broad range of inflammatory cytokines, such
as interleukin (IL)-1 and IL-2 produced by macrophages will
exert inflammatory effects and accelerate the progression of
AS (Signorelli et al., 2014; Eaton et al., 2015). Furthermore,
multiple evidences suggested that chronic inflammation could
be an independent risk factor to promote the atherogenesis. In
particular, the activation of STAT3, as a prominent modulator of
inflammation during AS, coordinates a platform for synergistic
amplification leading to pro-atherogenic responses (Szelag et al.,
2016). In addition, continued proinflammatory events could
activate macrophages to produce excessive reactive oxygen
species (ROS), which induces the apoptosis of foam cells and
is involved in the subsequent plaque formation in AS lesion
progression (Ekstrand et al., 2015; Manea et al., 2015). Besides,
imbalance of cholesterol influx, synthesis and eﬄux could
disrupt the cholesterol homeostasis and contribute the generation
of foam cells (Chistiakov et al., 2015). Therefore, inhibiting
the generation of inflammation and ox-LDL-induced lipid
deposition in macrophage and the modulation of intracellular
ROS levels may be attractive therapeutic strategies for preventing
AS (Back and Hansson, 2015).
As the natural medicine, Mongolian medicine has been
proven to treat CVDs effectively in clinical practice, with
the total efficiency over 90% (Meng, 2003; Jin and Chen,
2013; Shi, 2015). However, its development has been seriously
hampered due to the lack of complete theoretical system
and experimental researches. Therefore, it is very meaningful
to explore detailed molecular mechanisms to improve their
therapeutic management in AS. Quercetin (QCT) is a crucial
ingredient in Mongolian prescription Amin Erden (Shi, 2015).
It has to be mentioned that Amin Erden, as a commercialized
prescription of traditional Mongolian medicine, has been used to
treat CVDs and AS in China (Meng, 2003; Jin and Chen, 2013;
Shi, 2015). Several studies have demonstrated QCT markedly
inhibited the development of hypertension in hypertension
mouse model and the antihypertensive effects of QCT may be
due to enhanced eNOS activity and decreased NADPH oxidase-
mediated superoxide anion (O2) generation associated with
reduced p47 expression (Duarte et al., 2002; Sanchez et al.,
2006). The antioxidant property of QCT has also been mentioned
frequently on account of reducing the susceptibility of ox-LDL
and its aggregation in early stages of AS (Aviram et al., 1997).
In addition, QCT protects against oxidative damage in vitro
and in vivo through suppressing ROS generation (Abengozar-
Vela et al., 2015; Hu et al., 2015; Sharma et al., 2015; Ben
Salem et al., 2016). QCT has been reported to antagonize
STAT3 signaling in B-cell lymphoma and breast cancer cells (Li
et al., 2014; Seo et al., 2016) and down-regulate IL-6/STAT3
signaling in lung cancer cells (Mukherjee and Khuda-Bukhsh,
2015).
In the current study, we identify QCT as a negative regulator
of LPS-induced inflammation at least partly through suppressing
STAT3 signaling in macrophages. Furthermore, it is found
that OCT suppressed ox-LDL-induced lipid deposition and
ROS production. These findings suggest that QCT could be a
therapeutic agent for prevention and treatment of AS.
MATERIALS AND METHODS
Reagents
Quercetin, LPS (from Escherichia coli 0111:B4), Dimethyl
Sulfoxide (DMSO), 2′,7′-dichlorofluorescin diacetate (DCFH-
DA) and STAT3 inhibitor S3I-201 were purchased from Sigma
Chemical (St. Louis, MO, USA). Ox-LDL was purchased from
Shanghai Qcbio Science &Technologies Co., Ltd. QCT was
dissolved in DMSO (≥ 99.9%) and added into the medium
directly (the final work concentration of DMSO is 0.1%).
Macrophage Cell Line Culture
The murine RAW264.7 cell line was purchased from School
of Basic Medicine of Peking Union Medical College (Beijing,
China). Cells were cultured in Dulbecco’s Modified Eagle’s
Medium (2 mM glutamine, 1 mM pyruvate, 4.5 g/l glucose)
supplemented with 10% heat-inactivated fetal bovine serum
(FBS) (Gibco, USA) and antibiotics (100 U/ml penicillin and
streptomycin) (Gibco, USA) at 37◦C in a humidified atmosphere
of 5% CO2 (Wang et al., 2011). To evaluate the anti-atherogenic
effect of QCT, cells were randomly divided into three groups
in the following ways: control (vehicle DMSO); LPS/ox-LDL
treated; LPS/ox-LDL+QCT treated. Each group had a minimum
of three replicated wells. After 24 h of incubation, cells were
subjected to QCT at a final concentration of 20 µM for 24 h
(Jing et al., 2016), followed by treatment with LPS (500 ng/ml) for
another 6 h, or treated with ox-LDL (50 µg/ml) for an additional
24 h. Subsequently, cells were harvested and extracted for further
analysis.
RNA Extraction and Quantitative Real
Time PCR (qRT-PCR)
See the supporting information (Wang et al., 2008). Sequences of
the primers used for real-time PCR are given in Supplementary
Table S1.
Oil Red O Staining
RAW264.7 cells were divided into three groups [control (vehicle
DMSO), ox-LDL treated, ox-LDL+QCT treated] as described
above. Cells were pretreated with QCT (20 µM) or vehicle DMSO
for 24 h followed with/without ox-LDL (20 µg/ml) treatment
for another 24 h. Cell cultures were rinsed once with phosphate-
buffered saline (PBS) and fixed with 10% (v/v) formaldehyde for
15 min at room temperature. After washing three times with
double-distilled water (ddH2O), the cells were incubated with
filtered Oil Red O solution at room temperature for another
15 min, followed by further washing five times with ddH2O
to remove the background staining. Cells from each culture
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well were observed and photographed randomly under the
microscope (TE200; Nikon, Tokyo, Japan).
Cholesterol Quantitation Assay
To explore the effect of QCT on cholesterol accumulation in
macrophages, murine RAW264.7 cells were treated with ox-LDL
(20 µg/ml) and QCT (20 µM) as the method described above.
Cells were collected and processed for cholesterol extraction
(Cholesterol Quantitation Kit from Sigma-Aldrich, MAK043)
according to the instruction (Kain et al., 2015). Total or
free cholesterol concentration of samples was estimated using
commercial cholesterol quantitation kit (Sigma-Aldrich, USA)
by the automated analyzer according to the instruction and
previous report. Briefly, 50 µl of the diluted standards and
samples were incubated with 50 µl of reaction mixes containing
cholesterol assay buffer, cholesterol probe, cholesterol enzyme
mix, cholesterol esterase for 60 min at 37◦C. After incubation,
the absorbance was measured at 570 nm on a multiscan
spectrum (EnSpire Multimode Plate Readers, PerkinElmer) and
the cholesterol standard curve (0, 20, 40, 60, 80, 100 µg/ml) was
generated using the standard cholesterol solutions. All standards
and samples were run in duplicate.
Detection of ROS Production
To examine whether the production of ROS induced by ox-LDL
treatment could be blocked by QCT in macrophages, RAW264.7
cells were subjected to the treatment of QCT (20 µM) for 24 h
followed by ox-LDL (50 µg/ml) treatment for another 24 h.
ROS production was detected as described previously (Wang
et al., 2015). As non-fluorescent DCFH-DA could be de-esterified
intracellularly and turns into fluorescent 2′,7′-dichlorofluorescin
(DCFH) upon oxidation by free radicals, cells pellets were washed
with prechilled PBS and processed for DCFH-DA treatment for
60 min at 37◦C. Subsequently, ROS production in response to
oxidation in macrophages was detected by spectrofluorimetry,
which exciting light at 488 nm and emitting light at 525 nm.
Protein Extraction and Immunoblot
Detection of Phosphorylated STAT3
See the supporting information. Beta-actin was used as a loading
control.
Statistical Analysis
Error bar for the experiments represents the standard deviation
of the mean value (mean value ± SD) from at least three
independent experiments. All statistical analyses were carried out
using the SPSS.11 software (IBM, USA). The Student’s t-test was
used to calculate P-values between two groups. For comparisons
between multiple groups, a one-way ANOVA analysis was
performed. P-values of ≤0.05 were considered as statistically
significant.
RESULTS
QCT Inhibits LPS-Induced Inflammatory
Gene Expression in RAW264.7 Cells
Accumulation of vascular inflammation and immune cells is
an important nongenetic factor of AS. To determine whether
QCT suppressed inflammation response, we firstly investigated
the effects of QCT alone on non-stimulated cells. The results
showed that QCT alone decreased mRNA levels of IL-1α,
IL-1β, IL-10, COX-2, SOCS3, and LOX-1 (Supplementary
Figure S1). Moreover, we used LPS to induce inflammation
in RAW 264.7 cells. As shown in Figures 1A–F, activation
FIGURE 1 | Quercetin (QCT) inhibited inflammation in LPS-treated RAW264.7 cells. RAW 264.7 cells were grown in six-well plates for 24 h and treated with
20 µM QCT for 24 h, and then stimulated with 500 ng/ml of LPS for another 6 h. The cells were harvested and transcript levels of the following cytokines were
examined by qRT-PCR. Relative mRNA levels were shown in (A) IL-1α, (B) IL-1β, (C) IL-2, (D) IL-10, (E) MCP-1, and (F) COX-2.∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001 vs. the control group; #P < 0.05, ##P < 0.01 vs. the LPS-treated group. One-way ANOVA analysis was used to calculate P-values. The bars represent
mean ± SD. All data represent at least three independent experiments.
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of macrophages by LPS resulted in the increase of mRNA
levels of proinflammatory genes, such as IL-1α, IL-1β, IL-2,
IL-10, MCP-1, and COX-2, compared with the vehicle control
group. In contrast, treatment with QCT obviously attenuated
the LPS-induced mRNA expression of IL-1α, IL-1β, IL-2, IL-10,
MCP-1, and COX-2. Some of the results were also confirmed
using Enzyme-Linked Immunosorbent Assay (ELISA) assay. It
revealed that QCT suppressed IL-1β, MCP-1 and COX-2 protein
expression in RAW264.7 Cells (Supplementary Figure S2). In
addition, the effective treatment concentration of QCT used in
this study did not cause cytotoxic effect based on our MTT
assay (Supplementary Figure S3). We also determined the effects
of QCT with different concentrations on cytokine expression
triggered by LPS. It was found that QCT suppressed gene
expression of IL-1β, MCP-1 and COX-2 in a dose-dependent
manner (Supplementary Figure S4A). Taken together, these data
manifested that QCT might be an effective anti-inflammatory
agent.
QCT Treatment Inhibits LPS-Induced
Activation of STAT3 in RAW 264.7 Cells
The activation of STAT3 signal pathway has been reported
to be involved in controlling many key inflammatory genes
identified in AS. In the present work, to evaluate the underlying
mechanism by which QCT acts to suppress the LPS-induced
AS inflammation, we tested whether QCT antagonized STAT3
signaling pathway. As shown in Figure 2A, we found QCT
suppresses the mRNA levels of two STAT3 target genes SOCS3
and MMP-1 induced by LPS. IL-6 is a specific inducer for
STAT3 signaling. We found that IL-6 treatment alleviated
the suppression of QCT on LPS-induced mRNA levels of
IL-1α, IL-6, SOCS3, and iNOS (Supplementary Figure S5A).
Furthermore, we used antibody against IL-6 to test the role
of IL-6 in this process. We found that anti-IL-6 antibody
enhanced the effects of QCT on gene expression induced by
LPS (Supplementary Figure S5B). S3I-201, a specific inhibitor
of STAT3 activity, has been used to demonstrate a direct link
between QCT-induced inhibition of the STAT3 pathway and
other biological parameters. We found mRNA levels of some
proinflammatory genes in LPS+QCT group was similar to that
of LPS+S3I-201 group (Supplementary Figure S6). Prostaglandin
E2 (PGE2) is an inducer of STAT3. Inhibition of PGE2 synthesis
has been an important anti-inflammatory strategy (Ramanan
et al., 2016). We found QCT suppressed IL-6-induced PGE2
production in RAW264.7 cells (Supplementary Figure S7).
These results suggest that QCT could inhibit inflammatory
gene expression at least partially through suppressing STAT3
pathway.
The phosphorylation of STAT3 in RAW264.7 cells
treated with LPS was significantly increased as compared to
control groups (Figures 2B,C). By contrast, QCT treatment
significantly suppressed STAT3 phosphorylation induced by LPS
(Figures 2B,C). S3I-201 was used for negative control. Taken
FIGURE 2 | Quercetin treatment inhibits LPS-induced activation of STAT3 in RAW264.7 cells. (A) QCT suppresses SOCS3 and MMP-1 expression induced
by LPS. RAW264.7 cells were grown in six-well plates for 24 h and treated with 20 µM QCT for 24 h, and then stimulated with 500 ng/ml of LPS for another 6 h. The
cells were harvested and transcript levels of the following cytokines were examined by qRT-PCR. ∗P < 0.05 vs. the control group; #P < 0.05 vs. the LPS-treated
group. The bars represent mean ± SD. (B) Representative immunoblot showing phosphorylated STAT3 (p-STAT3) and total STAT3 (t-STAT3) protein levels in
RAW264.7 cells treated with DMSO, QCT (20 µM), LPS (500 ng/ml), LPS (500 ng/ml) + QCT (20 µM), and LPS (500 ng/ml) + S3I-201 (100 µM). β-actin as a
loading control. (C) Densitometry was used to quantify relative p-STAT3 protein levels normalized to t-STAT3 protein levels ∗P < 0.05 vs. control group; #P < 0.05
vs. LPS-induced group. One-way ANOVA analysis was used to calculate P-values. The bars represent mean ± SD. All data represent at least three independent
experiments.
Frontiers in Pharmacology | www.frontiersin.org 4 February 2017 | Volume 8 | Article 40
fphar-08-00040 February 1, 2017 Time: 15:2 # 5
Xue et al. Quercetin Inhibits Inflammation, Lipid Deposition
together, it suggests that QCT may exert an anti-inflammatory
effect on AS through inhibiting STAT3 pathway. We also tested
the effects of QCT on AKT and IκBα signaling pathways. We
found that QCT suppressed the phosphorylation of AKT induced
by LPS (Supplementary Figure S8) but not the phosphorylation
of IκBα (data not shown).
QCT Ameliorates ox-LDL-Induced
Inflammation in RAW264.7 Cells
Abundant evidences have confirmed that uptake of ox-LDL by
macrophages to form foam cells is another main determinant
for the endothelial dysfunction and development of AS. In
order to determine the anti-inflammation properties of QCT,
FIGURE 3 | Quercetin ameliorated oxidized low-density lipoproteins (ox-LDL)-induced inflammation in RAW264.7 cells. RAW264.7 cells growing in
six-well plates were pre-incubated with 20 µM of QCT for 24 h before treatment with 50 µg/ml of ox-LDL. Cells were harvested and transcript levels of IL-1β (A) and
LOX-1 (B) were measured by qRT-PCR. ∗P < 0.05 vs. the control group; #P < 0.05 and ##P < 0.01 vs. ox-LDL-induced group. One-way ANOVA analysis was used
to calculate P-values. The bars represent mean ± SD. All data represent at least three independent experiments.
FIGURE 4 | Quercetin decreased ox-LDL-induced lipid deposition in RAW264.7 cells. (A) Murine RAW264.7 cells treated with ox-LDL (20 µg/ml) and QCT
(20 µM) were fixed with formaldehyde for 15 min followed by stained with Oil Red O solution for an additional 15 min and then photographed randomly.
Representative photographs of Oil Red O stained cells in different groups were shown. (B) The percentage of Oil Red-positive cells to total cells was calculated using
Image-Pro Plus Image Analysis Software (Media Cybernetics, USA). (C) and (D) RAW264.7 cells were treated with ox-LDL and QCT as the method described
above. Total cholesterol concentrations (C) and free cholesterol concentrations (D) of cells in different groups were quantitatively analyzed by using cholesterol
quantitation kit. ∗∗∗P < 0.001 vs. the control group; ##P < 0.01, ###P < 0.001 vs. ox-LDL-induced group. One-way ANOVA analysis was used to calculate P-values.
The bars represent mean ± SD. All data represent at least three independent experiments.
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we pretreated RAW264.7 cells with QCT followed by stimulated
with ox-LDL. Compared with the control group, activation of
macrophages by ox-LDL leaded to the mRNA level increase
of proinflammatory gene IL-1β (Figure 3A) and induced the
transcription of LOX-1 (Figure 3B), which is the specific receptor
of ox-LDL. QCT treatment decreased the gene expression of IL-
1β (Figure 3A) and LOX-1 (Figure 3B) induced by ox-LDL. We
also determined the effects of QCT with different concentrations
on IL-1β and LOX-1 expression triggered by ox-LDL. It was
found that IL-1β and LOX-1 gene expression was suppressed by
QCT in a dose-dependent manner (Supplementary Figure S4B).
QCT Suppresses ox-LDL-Induced Lipid
Deposition in RAW264.7 Cells
Lipid accumulation in macrophages and the formation of foam
cells are crucial steps to promote the development of AS. To
investigate the effects of the QCT on ox-LDL-induced lipid
deposition, RAW264.7 cells were pretreated with QCT for 24 h
and then exposed to ox-LDL for another 24 h, followed by stained
with Oil Red O. Microscopic examination showed that ox-LDL
exposure increased the cytoplasmic lipid accumulation (number
of fat droplets) in macrophages compared with that in control
cells and supplementation of QCT markedly decreased ox-LDL-
induced the lipid levels through decreasing the percentage of Oil
Red-positive cells (Figures 4A,B). QCT treatment did not cause
the decrease in the number of cells in Oil Red staining results
(Supplementary Figure S9). Therefore, the Oil Red O staining
results indicate the inhibitory effects of QCT on cellular lipid
accumulation.
The generation of foam cells is related to the imbalance of
cholesterol influx, esterification and eﬄux. We detected obvious
increase of free cholesterol and total cholesterol accumulation in
ox-LDL-treated macrophages through biochemical analysis. In
contrast, QCT treatment induced significant reduction of total
cholesterol and free cholesterol concentration in ox-LDL-treated
cells, respectively (Figures 4C,D).
QCT Abrogates ox-LDL-Induced
Overproduction of ROS in RAW 264.7
Cells
Previous studies have proved that phagocytosis of ox-LDL
by macrophages gave rise to the activation of macrophage
and increased production of ROS, finally contributing to
atherosclerotic lesion progression. Therefore, we investigated the
effect of QCT on the generation of ROS. We found that 24 h
incubation with ox-LDL resulted in a remarkable increase of ROS
production (Figure 5A). QCT could significantly abrogate the
ox-LDL-induced overproduction of ROS. These results were also
confirmed using the OxiSelect ROS Assay Kit (Cell Biolabs Inc.)
(data not shown). Moreover, ox-LDL treatment diminished the
expression of SOD-1 transcript (Figure 5B). QCT increased the
SOD-1 levels reduced by ox-LDL in macrophages (Figure 5B),
indicating a significant antioxidant capacity of QCT.
DISCUSSION
Quercetin has been reported to decrease cytokine expression
in vitro and in vivo through antagonizing NF-κB and other
signaling pathways (Zhang et al., 2016; Zou et al., 2016). It
is reported that QCT also has antitumor functions through
suppressing STAT3 signaling (Li et al., 2014; Seo et al., 2016).
In addition, QCT protects against oxidative damage in vitro and
in vivo through suppressing ROS generation (Abengozar-Vela
et al., 2015; Hu et al., 2015; Sharma et al., 2015; Ben Salem et al.,
2016). In the current work, we show that QCT reduced levels of
inflammatory factors, induced by LPS through blocking STAT-3
pathway in RAW264.7 cells. We demonstrated that QCT is able
to inhibit LPS-induced inflammation and ox-LDL-induced lipid
deposition, which suggest that QCT could be a therapeutic agent
for the prevention and treatment of AS. In addition, QCT is one
of the main active constituents of the Mongolian prescription
“Amin Erden.” All data in the current work are indirect molecular
FIGURE 5 | Quercetin abrogated ox-LDL-induced overproduction of reactive oxygen species (ROS) in RAW264.7 cells. (A) Murine RAW264.7 cells
treated with ox-LDL (50 µg/ml) and QCT (20 µM) were processed for DCFH-DA treatment for 60 min. ROS production in response to oxidation and the subsequent
treatment of QCT in RAW264.7 cells was detected by spectrofluorimetry and quantified. (B) The expression of SOD-1 in RAW264.7 cells from different groups was
detected by qRT-PCR. ∗P < 0.05, ∗∗∗P < 0.001 vs. control group; #P < 0.05, ###P < 0.001 vs. ox-LDL-treated group. One-way ANOVA analysis was used to
calculate P-values. The bars represent mean ± SD. All data represent at least three independent experiments.
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evidences to prove the effectiveness of Amin Erden on AS, though
more experiments should be carried out in the future work.
Oxidized low-density lipoproteins has been demonstrated to
be crucial for the pathogenesis of AS and ox-LDL exposure to
endothelial cells or macrophages could be considered as a simple
model of AS in vitro. As the main ox-LDL receptor, LOX-1
has been confirmed to be closely involved in AS pathogenesis.
Overexpression of LOX-1 induces intramyocardial vasculopathy
in hyperlipidemic mice and the effect is probably mediated
through the endothelial dysfunction induced by LOX-1 (Inoue
et al., 2005). Conversely, deletion of LOX-1 could reduce the AS
in LDL receptor deficient mice fed with high cholesterol diet
(Mehta et al., 2007). In this study, we investigated the role of
LOX-1 in an ox-LDL induced AS model and found a protective
effect of QCT. It suggests that the decreased accumulation of lipid
observed in macrophages treated with QCT could be mediated by
the declining level of LOX-1.
Previous reports suggest that STAT3 controls the
inflammatory cascade more extensively in CVDs. Inflammation
in AS is partially due to the enhancement of STAT3 signaling. In
vascular smooth muscle cells (VSMCs) and macrophages, STAT3
has been confirmed to regulate the transcription of abundant
number of cytokines (Sahar et al., 2005). Moreover, decreasing
the phosphorylation of STAT3 suppressed both inflammation
and monocyte-to-macrophage differentiation (Vasamsetti et al.,
2015). In the current work, we found QCT treatment suppressed
the phosphorylation of STAT3 induced by LPS, which was
similar to the published observations for other natural flavonoids
(Wiejak et al., 2013). It indicates that QCT suppresses the
inflammation in AS through inhibiting the STAT3 pathway.
CONCLUSION
Treatment of QCT, as an important ingredient in Mongolian
medicine Amin Erden, could effectively suppress inflammation
response stimulated by LPS through inhibiting the
phosphorylation of STAT3. QCT reduces the lipid deposition
and ROS production induced by ox-LDL in RAW 264.7 cells.
Taken together, it is inspiring to demonstrate that QCT has
clinical value for the prevention and treatment of AS, and this
Mongolian prescription is worth to be promoted for anti-AS
therapy.
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